Catheter Precision (VTAK) Acquisitions (2023 - 2026)

Catheter Precision's (VTAK) quarterly Acquisitions came in at $1.2 million in Q1 2026, up 3933.33% on a QoQ basis from $30000.0 in Q4 2023.

Catheter Precision (VTAK) Acquisitions (2023 - 2026) Analysis & Trends

Catheter Precision (VTAK) has 2 years of Acquisitions data on file, last reported at $1.2 million in Q1 2026.

On a quarterly basis, Acquisitions changed N/A year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a N/A change from a year earlier, with the FY2023 full-year figure at $15000.0, changed N/A from the prior year.
Acquisitions for Q1 2026 stood at $1.2 million, up from $30000.0 in the prior quarter.
Over the last five years, Acquisitions for VTAK reached as high as $72.6 million in Q2 2023 and fell as low as -$72.6 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	22.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-268.10 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	2.30 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Catheter Precision	0.80	-811,999.20	390,000.00	1.21 Mn

Download Data